← Back
Data updated: Mar 29, 2026
DIFGEN PHARMS
Pharmaceuticals
Generics
DIFGEN PHARMS is a generic drug manufacturer with 13 FDA-approved products.
1997
Since
13
Drugs
-
Trials
72
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
FLUOROMETHOLONE 2026-02-12
LIDOCAINE 2026-02-09
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE 2026-01-21
FENTANYL-75 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE 2025-12-22
Labeling
FENTANYL-37 2025-12-22
Labeling
FENTANYL-37 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (12)
Discontinued (1)
Company Info
- First Approval
- 1997-10-20
- Latest
- 2026-02-12
- Applications
- 6